SEC Form 4 · accession 0001209191-15-037621
Viking Therapeutics, Inc. · VKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawson Macartney
Director
Period of report
Apr 28, 2015
Accepted (ET)
Apr 30, 2015 · 9:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001607678
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.00 | Apr 28, 2015 | A | 20,786 | A | — | Apr 28, 2025 | Common Stock | 20,786 | 20,786 | D |
Explanation of responses
- F1100% of the shares subject to the option shall vest on the date of the Issuer's first Annual Meeting of Stockholders following the date of grant, subject to the Reporting Person's continuous service on the Issuer's Board of Directors through immediately prior to such Annual Meeting.